|
Volumn 92, Issue 7, 1995, Pages 2484-2488
|
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
acquired immunodeficiency syndrome; antiviral; peptidomimetic
|
Indexed keywords
A 77003;
A 80987;
A 81525;
A 82200;
A 83962;
ANTIVIRUS AGENT;
PROTEINASE INHIBITOR;
RITONAVIR;
UNCLASSIFIED DRUG;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ANIMAL EXPERIMENT;
ANTIVIRAL ACTIVITY;
ARTICLE;
CLINICAL TRIAL;
DOG;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG METABOLISM;
DRUG POTENCY;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MONKEY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RAT;
STRUCTURE ACTIVITY RELATION;
VIRUS REPLICATION;
ADMINISTRATION, ORAL;
ANIMAL;
ANTIVIRAL AGENTS;
BILE;
BILE DUCTS;
BINDING SITES;
BIOLOGICAL AVAILABILITY;
CAPSULES;
COMPARATIVE STUDY;
FEMALE;
HIV PROTEASE;
HIV PROTEASE INHIBITORS;
HIV-1;
HIV-2;
HUMAN;
INJECTIONS, INTRAVENOUS;
MACACA FASCICULARIS;
MALE;
METABOLIC CLEARANCE RATE;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PYRIDINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RITONAVIR;
SUPPORT, U.S. GOV'T, P.H.S.;
TABLETS;
THIAZOLES;
TISSUE DISTRIBUTION;
VALINE;
ANIMALIA;
CANIS FAMILIARIS;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
|
EID: 0028968902
PISSN: 00278424
EISSN: None
Source Type: Journal
DOI: 10.1073/pnas.92.7.2484 Document Type: Article |
Times cited : (555)
|
References (23)
|